| Affordable Dentistry | |
|
700 S Mustang Rd Yukon OK 73099-6777 | |
| (405) 494-7227 | |
| Not Available |
| Full Name | Affordable Dentistry |
|---|---|
| Speciality | Dentist |
| Location | 700 S Mustang Rd, Yukon, Oklahoma |
| Authorized Official Name and Position | Ray D Tate (OWNER) |
| Authorized Official Contact | 4054204270 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Affordable Dentistry 700 S Mustang Rd Yukon OK 73099-6777 Ph: () - | Affordable Dentistry 700 S Mustang Rd Yukon OK 73099-6777 Ph: (405) 494-7227 |
| NPI Number | 1316432040 |
|---|---|
| Provider Enumeration Date | 06/25/2018 |
| Last Update Date | 07/13/2021 |
| Medicare PECOS PAC ID | 8426459439 |
|---|---|
| Medicare Enrollment ID | O20210917000413 |
News Archive
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
The more abnormalities in intestinal and brain function that IBS sufferers have, the more severe their symptoms of this functional bowel disorder, and the more adversely their everyday life is affected.
Targanta Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the November 19, 2008 Anti-Infective Drugs Advisory Committee (AIDAC) meeting.
A new study analyzing bean production and food security across 11 countries in sub-Saharan Africa, found COVID-19 pandemic-related restrictions to significantly impact bean production.
A Binghamton University researcher has established a new framework to help determine whether individuals might be at risk for schizophrenia.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316432040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
| Provider Name | Ray Dean Tate |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1558719245 PECOS PAC ID: 7416358437 Enrollment ID: I20210721000627 |
News Archive
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
The more abnormalities in intestinal and brain function that IBS sufferers have, the more severe their symptoms of this functional bowel disorder, and the more adversely their everyday life is affected.
Targanta Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the November 19, 2008 Anti-Infective Drugs Advisory Committee (AIDAC) meeting.
A new study analyzing bean production and food security across 11 countries in sub-Saharan Africa, found COVID-19 pandemic-related restrictions to significantly impact bean production.
A Binghamton University researcher has established a new framework to help determine whether individuals might be at risk for schizophrenia.
› Verified 4 days ago
| Provider Name | Hans C Igou |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1255778668 PECOS PAC ID: 4789069345 Enrollment ID: I20220916003228 |
News Archive
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
The more abnormalities in intestinal and brain function that IBS sufferers have, the more severe their symptoms of this functional bowel disorder, and the more adversely their everyday life is affected.
Targanta Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the November 19, 2008 Anti-Infective Drugs Advisory Committee (AIDAC) meeting.
A new study analyzing bean production and food security across 11 countries in sub-Saharan Africa, found COVID-19 pandemic-related restrictions to significantly impact bean production.
A Binghamton University researcher has established a new framework to help determine whether individuals might be at risk for schizophrenia.
› Verified 4 days ago
News Archive
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
The more abnormalities in intestinal and brain function that IBS sufferers have, the more severe their symptoms of this functional bowel disorder, and the more adversely their everyday life is affected.
Targanta Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the November 19, 2008 Anti-Infective Drugs Advisory Committee (AIDAC) meeting.
A new study analyzing bean production and food security across 11 countries in sub-Saharan Africa, found COVID-19 pandemic-related restrictions to significantly impact bean production.
A Binghamton University researcher has established a new framework to help determine whether individuals might be at risk for schizophrenia.
› Verified 4 days ago
Pediatric Dental Care, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1300 Crop Cir, Yukon, OK 73099 Phone: 214-702-0729 | |
Surrey Hills Dental Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12316 N Mustang Rd, Yukon, OK 73099 Phone: 405-373-2255 Fax: 405-373-2256 | |
1st Impressions Dentistry Of Yukon Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1401 S. Ranchwood Blvd., Ste. 110, Yukon, OK 73099 Phone: 405-354-4806 Fax: 405-354-1277 | |
Smile Today - Dentures And Implants Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 827 N Cemetery Rd Ste 6, Yukon, OK 73099 Phone: 405-652-1222 | |
Yukon Dentistry & Braces Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 901 E Main Street, Suite 100, Yukon, OK 73099 Phone: 405-493-0830 | |
Oklahoma Dental-yukon Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1300 Health Center Pkwy, Yukon, OK 73099 Phone: 405-354-1147 Fax: 405-842-9954 | |
Redeemed Smiles Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1730 Shedeck Parkway, Suites #100 And #105, Yukon, OK 73099 Phone: 405-237-6453 |